P-glycoprotein expression in lung cancer and progress in cisplatin resistance / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 565-567, 2011.
Article
em Zh
| WPRIM
| ID: wpr-419605
Biblioteca responsável:
WPRO
ABSTRACT
Cisplatin is widely used in lung cancer chemotherapy, but drug resistance seriously affects its efficacy.The mechanism of cisplatin resistance is not yet clear.Now it is widely recognized that P-glycoprotein (P-glycoprotein, P-gp) expression is associated with cisplatin resistance. Inhibition of P-gp expression can overcome cisplatin resistance and improve the treatment efficacy.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Cancer Research and Clinic
Ano de publicação:
2011
Tipo de documento:
Article